(704) 290-4587

RPL554-CO-302: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients with COPD

The purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Carolina Clinical Research is currently seeking study participants 18 years and older with a current COPD diagnosis . 

This study is currently sponsored by Verona Pharma PLC, in collaboration with Iqvia Pty Ltd. 

Click Here to read the full trial information 

 Click here to request participant information